<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="UTF-8">
  <meta http-equiv="X-UA-Compatible" content="IE=edge">
  <meta name="viewport" content="width=device-width, initial-scale=1.0">
  <link rel="shortcut icon" href="../figures/favicon.png" type="image/x-icon">
  <title>Endometriosis/Adenomiosis</title>
  <link rel="stylesheet" href="/style.css">
  <link rel="stylesheet" href="/notes.css">
</head>
<body>
  <input type="checkbox" id="main-navigation-toggle" class="btn btn--close" title="Toggle main navigation" />
  <label for="main-navigation-toggle">
    <span></span>
  </label>
  
  <a href="/index.html">
    <div class="home-navigation">
      M
    </div>
  </a>

  <nav id="main-navigation" class="nav-main">
    <ul class="menu">
      <li class="menu__item">
        <a class="menu__link" href="/index.html">Home</a>
      </li>
      <li class="menu__item">
        <a class="menu__link" href="/about-temp.html">About</a>
      </li>
      
     
      

      <li class="menu__item">
        <a class="menu__link" href="#0">Projects</a>
        <ul class="submenu">
          <li class="menu__item">
            <a class="menu__link" href="/404.html">Surgery</a>
          </li>
          <li class="menu__item">
            <a class="menu__link" href="/404.html">Pediatrics</a>
          </li>
        </ul>
      </li>
    </ul>
  </nav>
  
  <main class="page-container">
    <div class="contribute-cta">
      <p>Help make this betterüíú</p>
      <span><a href="/contribute.html">Contribute here</a> </span>
    </div>

    <h1>Endometriosis/Adenomiosis</h1>
  
    <!-- <div class="author-flex">
      <div class="author-img">
        <img  src="/contributors/vt1.jpeg" alt="">
      </div>
      <div>
        <h2 class="name">Compiled by Victortayo</h2>
        <p class="updated">last updated, Nov 2022</p>
      </div>
    </div> -->

    <article class="notes">
        <a id='top'></a>
    <article>
    <!-- <h2 class='title'>Outline</h2> -->
    <label class="trigger outline">
        <input type="checkbox" class="checkbox checkbox--red" /> Show/hide outline
        <div class="msg">
         <ol>
            <li><a href="#header-1">Introduction</a></li>
            <li><a href="#header-2">Diagnosis</a></li>
            <li><a href="#header-3">Investigation</a></li>
            <li><a href="#header-4">Treatment- pain</a></li>
            <li><a href="#header-5">Treatment- infertility</a></li>
            <li><a href="#header-6">Endometriosis & other conditions</a></li>
         </ol>
        </div>
      </label>

      <section id='header-1'>
        <header>
          <h2>
            <a aria-hidden='true' href='#header-1'>Introduction</a>
          </h2>
        </header>
        <div class='body'>
            <p><span class="special-text">Definition:</span></p>
            <p>Endometriosis refers to a condition in which endometrial-like tissues or stroma are found in locations other than the uterine lining.</p>
            <p>Adenomyosis is reserved for endometrial-like lesions within the myometrium (Previously endometriosis interna).</p>

            
        <figure>
            <img src="/figures/endometriosis (1).jpg" alt="">
            <figcaption>Fig. I. Endometriosis and adenomyosis.</figcaption>
        </figure>

            <p><span class="special-text">Epidemiology:</span></p>
            <p>Affects all races though seen more in whites</p>
            <p>Found almost exclusively in women of reproductive age</p>
            <p>Rare in pre-menarche and post-menopausal women</p>
            <p>Smoking, exercise and use of OCPs (current and recent) may be protective</p>

            <p><span class="special-text">Risk factors:</span></p>
            <p>Age</p>
            <p>Race</p>
            <p>Low parity </p>
            <p>Familial tendency</p>
            <p>Early menarche / late menopause </p>
            <p>High estrogen </p>
            <p>Environmental Factors like pollutants </p>

            <figure>
                <img src="/figures/endometriosis (1).png" alt="">
                <figcaption>Fig. II. Age at diagnosis.</figcaption>
            </figure>

            <p><span class="special-text">Prevalence:</span></p>
            <p>Present in 20-45% (infertile) & 1-5% (fertile) women </p>
            <p>Population based studies: 6.2 - 7.9%</p>
            <p>Epidemiology studies:   0.25 new cases /1000 WY</p>



        </div>

      </section>

      <section id='header-2'>
        <header>
          <h2>
            <a aria-hidden='true' href='#header-2'>Diagnosis </a>
          </h2>
        </header>
        <div class='body'>
            <p><span class="special-text">Late diagnosis:</span></p>
            <p>Several studies have reported large diagnostic delays in endometriosis. </p>
            <p>10.4 years in Germany and Austria (Hudelist, et al., 2012).</p>
            <p>8 years in the UK and Spain (Ballard, et al., 2006, Nnoaham, et al., 2011).</p>
            <p>Reasons for diagnostic delay</p>
            <ul>
                <li>Intermittent use of contraceptives causing hormonal suppression of symptoms</li>
                <li>Misdiagnosis</li>
                <li>Attitude towards menstruation </li>
                <li>Normalisation of pain by the women, their mothers, health workers, gynecologists or other ‚Äúspecialists‚Äù </li>
            </ul>

          <section id='heading-2-1'>
            <header>
              <h3>
                <a aria-hidden href='#heading-2-1'>Making a diagnosis </a>
              </h3>
            </header>
            <div class='body'>
                <ul>
                    <li>Symptoms</li>
                    <li>Signs </li>
                    <li>Findings on Investigations</li>
                </ul>
               <p>Overall, the evidence on symptoms/signs that indicate a diagnosis of endometriosis is weak and incomplete.</p>

              <section id='heading-2-1-1'>
                <header>
                  <h4>
                    <a aria-hidden href='#heading-2-1-1'>Symptoms</a>
                  </h4>
                </header>
                <div class='body'>
                    <p><span class="special-text">Reproductive tract:</span></p>
                    <ul>
                        <li>Spasmodic dysmenorrhoea</li>
                        <li>Lower abdominal pain, lower back pain                                                                                            </li>
                        <li>Menstrual disorders</li>
                        <li>Deep dyspareunia</li>
                        <li>Infertility </li>
                        <li>Cyclical vulval pain   </li>
                    </ul>

                    <p><span class="special-text">Urinary tract:</span></p>
                    <ul>
                        <li>Cyclical dysuria</li>
                        <li>Hematuria</li>
                        <li>Ureteric obstruction (loin pain)</li>
                    </ul>

                    <p><span class="special-text">GIT:</span></p>
                    <ul>
                        <li>Dyschezia</li>
                        <li>Cyclical rectal bleeding		</li>
                        <li>Hematochezia</li>
                        <li>Cyclical pain/bluish swelling/bleeding of abdominal scars</li>
                    </ul>

                    <p><span class="special-text">Lung:</span></p>
                    <ul>
                        <li>Cyclical</li>
                        <li>Hemoptysis </li>
                        <li>Catamenial pneumothorax</li>
                        <li>Pleural effusion</li>
                    </ul>

                    <p><span class="special-text">CNS:</span></p>
                    <ul>
                        <li>Catamenial seizures</li>
                        <li>Headache </li>
                    </ul>

                    <p><span class="special-text">MSK:</span></p>
                    <ul>
                        <li>Limb pain</li>
                        <li>Sciatica </li>
                    </ul>

                    

                </div>
              </section>

              <section id='heading-2-1-2'>
                <header>
                  <h4>
                    <a aria-hidden href='#heading-2-1-2'>Key symptoms</a>
                  </h4>
                </header>
                <div class='body'>
                    <p>Dysmenorrhea</p>
                    <p>Infertility</p>
                    <p>Dyspareunia  </p>
                    <p>Post-coital bleeding </p>
                    <p>Presence of ovarian cyst </p>
                    <p>Irritable bowel syndrome </p>
                    <p>Chronic pelvic pain </p>

                    <p><i>According to Bellelis, et al., 2010:</i></p>
                    <ul>
                        <li>Dysmenorrhea was the chief complaint, reported by 62% of women </li>
                        <li>Chronic pelvic pain was 57%</li>
                        <li>Deep dyspareunia 55% </li>
                        <li>Cyclic intestinal complaints 48% </li>
                        <li>Infertility 40% </li>
                        <li>Incapacitating dysmenorrhea 28%</li>
                    </ul>
                </div>
              </section>

              <section id='heading-2-1-3'>
                <header>
                  <h4>
                    <a aria-hidden href='#heading-2-1-3'>Signs</a>
                  </h4>
                </header>
                <div class='body'>
                    <p>There may be no signs</p>
                    <p>The tissues may be found in scars</p>
                    <p>Abdominal tenderness may be noted</p>
                    <p>Pelvic examination may show‚Äî</p>
                    <ul>
                        <li>Perineal, vaginal and cervical lesions</li>
                        <li>Tender nodules may be palpated in rectovaginal septum and  uterosacral ligaments</li>
                        <li>Adnexal tenderness, and masses may be noted</li>
                        <li>Uterus may be fixed or retroverted</li>
                        <li>Tender, nodular or boggy pouch of Douglas</li>
                    </ul>
                    <p>Findings most reliable when examination is performed during menstruation</p>

                    <figure>
                        <img src="/figures/endometriosis.jpg" alt="">
                        <figcaption>Fig. III. Endometriosis.</figcaption>
                    </figure>

                    <figure>
                      <img src="/figures/endometriosis.png" alt="">
                      <figcaption>Fig. IV. Endometriosis.</figcaption>
                    </figure>

                    <figure>
                      <img src="/figures/endometriosis (9).png.jpg" alt="">
                      <figcaption>Fig. V. Lesion outside the pelvis.</figcaption>
                    </figure>

                    <p><span class="special-text">Recommendations:</span></p>
                    <p>Consider the diagnosis of endometriosis in the presence of gynecological symptoms such as: dysmenorrhea, non-cyclical pelvic pain, deep dyspareunia, infertility. (Grade of recommendation:  GPP).</p>
                    <p>Clinicians should consider the diagnosis of endometriosis in women of reproductive age with non-gynecological cyclical symptoms (dyschezia, dysuria, hematuria, rectal bleeding, and shoulder pain). (Grade of recommendation:  GPP).</p>
                    <p>Clinicians may consider the diagnosis of deep endometriosis in women with (painful) induration and/or nodules of the rectovaginal wall found during clinical examination, or visible vaginal nodules in the posterior vaginal fornix (Bazot, et al., 2009). (Grade of recommendation: C).</p>
                    <p>Clinicians may consider the diagnosis of ovarian endometrioma in women with adnexal masses detected during clinical examination. (Grade of recommendation: C).</p>
                    <p>Clinicians may consider the diagnosis of endometriosis in women suspected of the disease even if the clinical examination is normal (Chapron, et al., 2002). (Grade of recommendation: C).</p>

                </div>
              </section>
            </div>
          </section>

        </div>
      </section>

      <section id='header-3'>
        <header>
          <h2>
            <a aria-hidden='true' href='#header-3'>Investigations</a>
          </h2>
        </header>
        <div class='body'>
            <ul>
                <li>Laparoscopy</li>
                <li>Histology</li>
                <li>Ultrasound [TVS]</li>
                <li>MRI</li>
                <li>Biomarkers</li>
            </ul>

            <p>Laparoscopy with histology is diagnostic.</p>
            <p>Uterine Fibroid growth is estrogen dependent.</p>
            <section id='heading-3-1'>
              <header>
                <h3>
                  <a aria-hidden href='#heading-3-1'>Laparoscopy</a>
                </h3>
              </header>
              <div class='body'>
                 <p>Gold standard.</p>
                 <p>The combination of laparoscopy and the histological verification of endometrial glands and/or stroma is considered to be the gold standard for the diagnosis of the disease.</p>
                 <ul>
                  <li>Accuracy depends on surgeon</li>
                  <li>Systematic inspection of pelvis required </li>
                  <li>Document type, location and extend of all lesions</li>
                  <li>Histologic confirmation is a good practice</li>
                 </ul>

                 <figure>
                  <img src="/figures/endometriosis (2).png" alt="">
                  <figcaption>Fig. VI. Endometriosis. </figcaption>
                 </figure>

                 <figure>
                  <img src="/figures/endometriosis (3).png" alt="">
                  <figcaption> Fig. VII. Endometriosis.</figcaption>
                 </figure>

                 <figure>
                  <img src="/figures/endometriosis (4).png" alt="">
                  <figcaption>Fig. VIII. Endometriosis. </figcaption>
                 </figure>

                 <figure>
                  <img src="/figures/endometriosis (5).png" alt="">
                  <figcaption>Fig. IX. Endometriosis. </figcaption>
                 </figure>

                 <figure>
                  <img src="/figures/endometriosis (6).png" alt="">
                  <figcaption>Fig. X. Endometriosis. </figcaption>
                 </figure>

                 <figure>
                  <img src="/figures/endometriosis (7).png" alt="">
                  <figcaption>Fig. XI. Endometriosis. </figcaption>
                 </figure>

                 <p><span class="special-text">Staging:</span></p>
                 <ul>
                  <li>Stage 1 (minimal): 1-5</li>
                  <li>Stage2 (mild):6-15</li>
                  <li>Stage 3 (moderate):16-40</li>
                  <li>Stage 4 (severe): >40</li>
                 </ul>

                 <figure>
                  <img src="/figures/endometriosis (8).png" alt="">
                  <figcaption>Fig. XI. Staging/classification of Endometriosis. </figcaption>
                 </figure>

                 <p><span class="special-text">Recommendation:</span></p>
                 <p>That clinicians perform a laparoscopy to diagnose endometriosis, although evidence is lacking that a positive laparoscopy without histology proves the presence of disease. (Grade of recommendation: GPP).</p>
              </div>
            </section>

            <section id='heading-3-2'>
              <header>
                <h3>
                  <a aria-hidden href='#heading-3-2'>Histology </a>
                </h3>
              </header>
              <div class='body'>
                 <p><span class="special-text">Ovarian Endometrioma</span></p>
                 <p>That clinicians obtain tissue for histology in women undergoing surgery for ovarian endometrioma and/or deep infiltrating disease, to exclude rare instances of malignancy. (Grade of recommendation: GPP).</p>
              </div>
            </section>

            <section id='heading-3-3'>
              <header>
                <h3>
                  <a aria-hidden href='#heading-3-3'>Transvaginal USS</a>
                </h3>
              </header>
              <div class='body'>
                 <p>In women with symptoms and signs of rectal endometriosis, transvaginal sonography is useful for identifying or ruling out rectal endometriosis (Hudelist, et al., 2011). (Grade of recommendation: A).</p>
                 <p>Clinicians are recommended to perform transvaginal sonography to diagnose or to exclude an ovarian endometrioma (Moore, et al., 2002).</p>
                 <ul>
                  <li>Ground glass echogenicity </li>
                  <li>One to four compartments  </li>
                  <li>No papillary structures with detectable blood flow.</li>
                 </ul>
                 <p>(Grade of recommendation: A).</p>
              </div>
            </section>

            <section id='heading-3-4'>
              <header>
                <h3>
                  <a aria-hidden href='#heading-3-4'>MRI</a>
                </h3>
              </header>
              <div class='body'>
                 <p>Clinicians should be aware that the usefulness of magnetic resonance imaging (MRI) to diagnose peritoneal endometriosis is not well established (Stratton, et al., 2003).</p>
                 <ul>
                  <li>90% sensitivity and specificity not supported by recent review</li>
                  <li>Superior to ultrasound</li>
                  <li>May be used to monitor prognosis</li>
                 </ul>
                 <p>(Grade of recommendation: D).</p>
              </div>
            </section>

            <section id='heading-3-5'>
              <header>
                <h3>
                  <a aria-hidden href='#heading-3-5'></a>
                </h3>
              </header>
              <div class='body'>
                 <p>Clinicians are recommended not to use immunological biomarkers, including CA-125, in plasma, urine or serum to diagnose endometriosis (May, et al., 2010, Mol, et al., 1998). (Grade of recommendation: GPP).</p>
                 <p></p>
              </div>
            </section>
        </div>
      </section>

      <section id='header-4'>
        <header>
          <h2>
            <a aria-hidden='true' href='#header-4'>Treatments- pain</a>
          </h2>
        </header>
        <div class='body'>
            <p>Women with endometriosis are confronted with one or both of two major problems- endometriosis associated pain and/or infertility./</p>          
            <p><span class="special-text">Pain </span></p>
            <p>Pain is generally premenstrual and mostly due to</p>
            <ul>
              <li>Adhesions with traction on tissues</li>
              <li>Nerve entrapment, pressure symptoms</li>
              <li>Bradykinin and PG release especially PGF</li>
              <li>Site and depth of implants</li>
            </ul>
            <p>Severity of pain does no correlate to severity of disease</p>

            <p><span class="special-text">Infertility </span></p>
            <p>No agreement on the mechanism in minimal and mild disease. </p>
            <p>Altered peritoneal fluid and contents seem to be implicated.</p>
            <ul>
              <li>Ovarian function ‚Äì endocrinopathy ‚Äì anovulation. Rate of ovulation is reduced by 11-27% - nearly ¬Ω get pregnant when this is corrected.</li>
              <li>Coital function‚Äî dyspareunia causing decrease frequency of coitus and reduced penetration</li>
              <li>Tubal function‚Äî PG alters tubal & cilial motility. Impaired fimbrial activity.</li>
              <li>Sperm function‚Äî phagocytosis, inactivation by antibodies.</li>
              <li>Endometrium‚Äî Implantation defects</li>
              <li>Early pregnancy failure‚Äî Increased early abortion & PG induced immune reaction</li>
            </ul>

            <section id='heading-4-1'>
              <header>
                <h3>
                  <a aria-hidden href='#heading-4-1'>Medical treatment</a>
                </h3>
              </header>
              <div class='body'>
                 <p>Endometriosis associated Pain </p>
                 <ul>
                  <li>Use of NSAIDS</li>
                 </ul>
                 <p>Clinicians are recommended to prescribe hormonal treatment for endometriosis associated pain.</p>
                 <ul>
                  <li>Hormonal contraceptives (level B)</li>
                  <li>Progestogens (level A)</li>
                  <li>Anti-progestogens (level A)</li>
                 </ul>
                 <p>Or</p>
                 <ul>
                  <li>GnRH agonists (level A)</li>
                 </ul>
                 <p>Clinicians should take patient preferences, side effects, efficacy, costs and availability into consideration when choosing hormonal treatment for endometriosis-associated pain. (Grade of recommendation: GPP).</p>
              </div>

              <section id='heading-4-1-1'>
                <header>
                  <h3>
                    <a aria-hidden href='#heading-4-1-1'>Combined oral contraceptives</a>
                  </h3>
                </header>
                <div class='body'>
                   <p>Clinicians can consider prescribing a combined hormonal contraceptive, as it reduces endometriosis-associated dyspareunia, dysmenorrhea and non-menstrual pain (Vercellini, et al., 1993).</p>
                   <p>Clinicians may consider the continuous use of a combined oral contraceptive pill in women suffering from endometriosis-associated dysmenorrhea (Vercellini, et al., 2003).</p>
                </div>
              </section>

              <section id='heading-4-1-2'>
                <header>
                  <h3>
                    <a aria-hidden href='#heading-4-1-2'>Progestogens</a>
                  </h3>
                </header>
                <div class='body'>
                   <p>Clinicians are recommended to use progestogens [medroxyprogesterone acetate (oral or depot), dienogest, cyproterone acetate, norethisterone acetate or danazol] or anti-progestogens (gestrinone) as one of the options, to reduce endometriosis-associated pain (Brown, et al., 2012). (Grade of reccomendation: A).</p>
                </div>
              </section>

              <section id='heading-4-1-3'>
                <header>
                  <h3>
                    <a aria-hidden href='#heading-4-1-3'>GNRH agonist</a>
                  </h3>
                </header>
                <div class='body'>
                   <p>Clinicians are recommended to use GnRH agonists (nafarelin, leuprolide, buserelin, goserelin or triptorelin), as one of the options for reducing endometriosis-associated pain, although evidence is limited regarding dosage or duration of treatment (Brown, et al., 2010). (Grade of recommendation: A).</p>
                   <p>Clinicians to give careful consideration to the use of GnRH agonists in young women and adolescents, since these women may not have reached maximum bone density. (Grade of recommendation: GPP).</p>
                </div>
              </section>

              <section id='heading-4-1-4'>
                <header>
                  <h3>
                    <a aria-hidden href='#heading-4-1-4'>Add Back</a>
                  </h3>
                </header>
                <div class='body'>
                   <p>Clinicians are recommended to prescribe hormonal add-back therapy to coincide with the start of GnRH agonist therapy, to prevent bone loss and hypoestrogenic symptoms during treatment. (Bergqvist, et al., 1997, Makarainen, et al., 1996, Moghissi, et al., 1998, Taskin, et al., 1997). (Grade of recommendation: A).</p>
                </div>
              </section>
            </section>

            <section id='heading-4-2'>
              <header>
                <h3>
                  <a aria-hidden href='#heading-4-2'>Surgical treatment</a>
                </h3>
              </header>
              <div class='body'>
                 <p>For endometriosis associated pain </p>
                 <p>Laparoscopy preferred to open surgery</p>
                 <ul>
                  <li>Elimination of endometriotic lesions</li>
                  <li>Division of adhesions </li>
                  <li>Interruption of nerve pathways</li>
                  <li>Hysterectomy with BSO</li>
                 </ul>

                 <p><i>See and treat:</i></p>
                 <p>When endometriosis is identified at laparoscopy, clinicians are recommended to surgically treat endometriosis, as this is effective for reducing endometriosis-associated pain i.e. ‚Äòsee and treat‚Äô (Jacobson, et al., 2009). (Grade of recommendation: A).</p>

                 <p><span class="special-text">Recommendation:</span></p>
                 <p>Clinicians clearly distinguish </p>
                 <ul>
                  <li>Adjunctive short-term (< 6 months) hormonal treatment after surgery.</li>
                  from
                  <li>Long-term (> 6 months) hormonal treatment; the latter is aimed at secondary prevention.</li>
                 </ul>

                 <p>Clinicians should not prescribe adjunctive hormonal treatment in women with endometriosis for endometriosis-associated pain after surgery, as it does not improve the outcome of surgery for pain (Furness, et al., 2004). (Grade of recommendation: A).</p>
                 <p>The GDG states that there is a role for prevention of recurrence of disease and painful symptoms in women surgically treated for endometriosis. </p>
                 <p>The choice of intervention depends on patient preference, cost, availability and side effects. For many interventions that might be considered here, there are limited data. (Grade of recommendation: GPP).</p>

                 <p><span class="special-text">LUNA</span></p>
                 <p>Clinicians should not perform laparoscopic uterosacral nerve ablation (LUNA) as an additional procedure to conservative surgery to reduce endometriosis-associated pain (Proctor, et al., 2005). (Grade of recommendation: A).</p>

                 <p><span class="special-text">PSN</span></p>
                 <p>Clinicians should be aware that presacral neurectomy (PSN) is effective as an additional procedure to conservative surgery to reduce endometriosis-associated midline pain, but it requires a high degree of skill and is a potentially hazardous procedure (Proctor, et al., 2005). (Grade of recommendation:  A).</p>


              </div>
            </section>
        </div>
      </section>

      <section id='header-5'>
        <header>
          <h2>
            <a aria-hidden='true' href='#header-5'>Treatments- infertility</a>
          </h2>
        </header>
        <div class='body'>
            <p><span class="special-text">Hormonal treatment</span></p>
            <p>In infertile women with endometriosis, clinicians should not prescribe hormonal treatment for suppression of ovarian function to improve fertility (Hughes, et al., 2007). (Grade of recommendation: A).</p>

            <p><span class="special-text">Early laparoscopy</span></p>
            <p>In infertile women clinicians can consider operative laparoscopy, instead of expectant management, to increase spontaneous pregnancy rates (Nezhat, et al., 1989, Vercellini, et al., 2006a). (Grade of recommendation: B).</p>

            <p><span class="special-text">Adjunctive hormone treatment</span></p>
            <p>In infertile women with endometriosis, clinicians should not prescribe adjunctive hormonal treatment after surgery to improve spontaneous pregnancy rates (Furness, et al., 2004). (Grade of recommendation: A).</p>

            <p><span class="special-text">Endometriosis and ART</span></p>
            <p>Use of assisted reproductive technologies for infertility associated with endometriosis is recommended, especially if tubal function is compromised or if there is male factor infertility, and/or other treatments have failed. (Grade of recommendation: GPP).</p>

            <p><span class="special-text">IUI with COS</span></p>
            <p>In infertile women, consider performing intrauterine insemination with controlled ovarian stimulation within 6 months after surgical treatment, since pregnancy rates are similar to those achieved in unexplained infertility (Werbrouck, et al., 2006). (Grade of recommendation: C).</p>

            <p><span class="special-text">IVF/ICSI</span></p>
            <p>Recommends the use of assisted reproductive technologies for infertility associated with endometriosis, especially if tubal function is compromised or if there is male factor infertility, and/or other treatments have failed. (Grade of recommendation:  GPP).</p>

            <p><span class="special-text">GNRH prior to ART</span></p>
            <p>Clinicians can prescribe GnRH agonists for a period of 3 to 6 months prior to treatment with assisted reproductive technologies to improve clinical pregnancy rates in infertile women with endometriosis (Sallam, et al., 2006). (Grade of recommendation: B).</p>
        </div>
      </section>

      <section id='header-6'>
        <header>
          <h2>
            <a aria-hidden='true' href='#header-6'>Endometriosis and other conditions</a>
          </h2>
        </header>
        <div class='body'>
           <p><span class="special-text">Menopause and Endometriosis</span></p>
           <p>In postmenopausal women after hysterectomy and with a history of endometriosis, avoid unopposed estrogen treatment. </p>
           <p>However, the theoretical benefit of avoiding disease reactivation should be balanced against the increased systemic risks associated with combined estrogen/progestogen or tibolone. (Grade of recommendation:  GPP).</p>
           <p>In women with surgically induced menopause because of endometriosis, estrogen/progestagen therapy or tibolone can be effective for the treatment of menopausal symptoms (Al Kadri, et al., 2009). (Grade of recommendation:  B).</p>

           <p><span class="special-text">Endometriosis and Cancer</span></p>
           <p>There is no evidence that endometriosis causes cancer.</p>
           <p>There is no increase in overall incidence of cancer in women with endometriosis, </p>
           <p>Some cancers (ovarian cancer and non-Hodgkin‚Äôs lymphoma) are slightly more common in women with endometriosis. (Grade of recommendation: GPP).</p>

        </div>
      </section>


      </section>

      <div class="contact">
        <hr style="margin: 3rem 0;">

        <p>Send us a <a href="mailto:cohs.materia@gmail.com"><span class="special-text-2">mail</span></a> at 
         <br> cohs.materia@gmail.com.</p>
        <p>Or send your comments, corrections, explanations/clarifications and requests/suggestions to our 
         <br> <a href="" class="special-text-2" style="text-decoration: none;">WhatsApp group</a>.</p>
      </div>
    </article>
   </article>
   <div style="height: 300px;"></div>
  </main>

  <footer>
    <div class="footer-container">
        <div>
          <p>obgyn.materia</p>
          <span>üßò‚Äç‚ôÄÔ∏èüé∂üßò‚Äç‚ôÇÔ∏è </span>
        </div>
    </div>
  </footer>
</body>
</html>
 
